DxtER includes a group of non-invasive sensors that can communicate with a smart device as they collect data on vital signs, body chemistry and biological functions.
But DxtER had a problem. The platform had too many potential uses to become a single product.
Originally posted on Medical Design & Outsourcing
By Nancy Crotti
After Basil Leaf Technologies won the Qualcomm Tricorder XPrize in 2017, founder Dr. Basil Harris needed help figuring out how to bring this almost-all-in-one diagnostic tool to market.
Basil Leaf’s mobile platform DxtER includes a group of non-invasive sensors that can wirelessly communicate with a smart device as they collect data on vital signs, body chemistry and biological functions. An artificially intelligent engine at the heart of DxtER learned to diagnose by integrating ER practices with data analysis from actual patients with a variety of medical conditions and outcomes.
A Philadelphia-area emergency room doctor with a PhD in engineering, Harris worked with his brother, network engineer George Harris, and their Final Frontier Medical Device team to invent their version of the tricorder of Star Trek fame. Armed with the $2 million XPrize, Harris started shopping DxtER around to device development companies. He chose Smithwise of Newtown Square, Pa. and Newton, Mass. to help with engineering and regulatory issues.
But DxtER had a problem. The platform had too many potential uses to become a single product.